Symposium 1: Primary and secondary lipodystrophy

Authors

  • Carla Musso Favaloro Foundation; "César Milstein" Assistance Unit, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v54i3Sup.315

Keywords:

lipodystrophy, characteristics

Abstract

Symposium 1: When diabetes is not autoimune

Primary and secondary lipodystrophy

Lipodystrophy is a complex disease, which can be either congenital or acquired, characterized by the loss of subcutaneous fat, total or partial, with the increase of visceral fat. There are multiple molecular forms found; the first ones described are type 1 and type 2 congenital generalized lipodystrophy syndrome. Several patients exhibit molecular forms that have yet to be described. Type 1 has been found in chromosome 9q34 and it is the mutation of 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT2) that catalyzes acetylation reaction during phospholipid and triglycerides synthesis, especially at a subcutaneous adipose tissue level. Type 2 is a mutation in the seipin gene, which encodes a protein of a still unknown function. That is the reason why the mechanisms by which lipodystrophy is unchained are also still unknown. It is located in chromosome 11q13.

Author Biography

Carla Musso, Favaloro Foundation; "César Milstein" Assistance Unit, Autonomous City of Buenos Aires, Argentina

Endocrinologist Physician, Diabetes Service, Favaloro Foundation; Staff Physician of the "César Milstein" Assistance Unit

Published

2023-01-10

How to Cite

Musso, C. (2023). Symposium 1: Primary and secondary lipodystrophy. Journal of the Argentine Society of Diabetes, 54(3Sup), 11–11. https://doi.org/10.47196/diab.v54i3Sup.315

Most read articles by the same author(s)

1 2 3 > >>